✦ LIBER ✦

Effect of IFNβ and anti-IFNβ antibodies on NK cells in multiple sclerosis patients

✍ Scribed by P. Perini; M. Wadhwa; M. Buttarello; A. Meager; A. Facchinetti; R. Thorpe; G. Biasi; P. Gallo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Guidelines on use of anti-IFN-β antibody

✍ P. S. Sørensen; F. Deisenhammer; P. Duda; R. Hohlfeld; K.-M. Myhr; J. Palace; C. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

IFNβ bioavailability in multiple scleros

✍ Ruggero Capra; Alessandra Sottini; Cinzia Cordioli; Federico Serana; Marco Chiar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 467 KB

The importance of measuring IFNβ bioacti

✍ Andrew R. Pachner; Donna Dail; Elena Pak; Kavitha Narayan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 223 KB

The IgG subclass-specificities of anti-I

✍ Ebrima Gibbs; Joel Oger 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Glatiramer acetate and IFN-β act on dend

✍ Yassir Hussien; Alessandra Sanna; Mats Söderström; Hans Link; Yu-Min Huang 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Guidelines on use of anti-IFN-B antibody

✍ J. S. Burks; A. Noronha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB